Locally Advanced Unresectable Soft Tissue Sarcoma
1 clinical trials · Condition
◉ Watch Locally Advanced Unresectable Soft Tissue Sarcoma
| Record | Firm | Date |
|---|---|---|
| Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma (NCT05836571) | National Cancer Institute LAO | 2023-10-25 |
Track Locally Advanced Unresectable Soft Tissue Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.